# Immune activation and response to pembrolizumab in POLE-mutant endometrial cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/immune-activation-and-response-to-pembrolizumab-in-pole-mutant-endometrial/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Janice M. Mehnert,Anshuman Panda,Judy Zhong,Kim M. Hirshfield,Sherri Damare,Katherine Lane,Levi Sokol,Mark N. Stein,Lorna Rodriguez-Rodriquez,Howard L. Kaufman,Siraj M. Ali,Jeffrey S. Ross,Dean C. Pavlick,Gyan Bhanot,Eileen White,Robert S. DiPaola,Ann Lovell,Jonathan D. Cheng,Shridar Ganesan |
| Citations | 392 |
| DOI | 10.1172/jci84940 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | http://www.jci.org/articles/view/84940/files/pdf |
| OpenAlex ID | https://openalex.org/W2383119765 |
| PMID | 27159395 |
| Type | article |
| Year | 2016 |

## Paper authors

- [Kim M. Hirshfield](https://scholariq.org/researchers/kim-m-hirshfield/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Endometrial and Cervical Cancer Treatments](https://scholariq.org/topics/endometrial-and-cervical-cancer-treatments/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.